ADVANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sphere of biopharmaceuticals, offering promising progress across many professional medical and industrial programs. With its structural similarity to naturally derived human serum albumin, OsrHSA offers a safer, additional responsible alternative for therapeutic